Nucleic acid sequence measuring apparatus, nucleic acid sequence measuring method, nucleic acid sequence measuring program, and nucleic acid sequence measuring device
The nucleic acid sequence measuring device addresses light variation issues by using measurement and reference regions with correction methods, enhancing reliability and accuracy in nucleic acid sequence detection.
Patent Information
- Application Number
- JP2023083113
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-19
- Publication Date
- 2024-11-29
AI Technical Summary
Variations in the amount of spot light emitted from nucleic acid sequence measurement devices can lead to decreased detection sensitivity and reliability due to false positives or false negatives, and these variations can occur between manufacturing lots, devices, blocks, and spots within a device, as well as over time.
The nucleic acid sequence measuring device incorporates measurement regions that emit fluorescence upon target reaction and reference regions that emit fluorescence independently of the target, using a calculation unit to correct or normalize the light amount based on the reference regions, employing coefficients and regression analyses to account for spatial and temporal variations.
This approach allows for higher reliability in nucleic acid sequence measurement by correcting for variations in spot light, ensuring accurate detection of targets even with changes over time or between devices.
Smart Images

Figure 2024166777000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a nucleic acid sequence measuring apparatus, a nucleic acid sequence measuring method, a nucleic acid sequence measuring program, and a nucleic acid sequence measuring device. [Background technology]
[0002] A widely known method for measuring a target having a specific nucleic acid sequence contained in a sample is to use a DNA chip (a detection probe having a complementary sequence to the specific nucleic acid sequence is provided on a solid phase surface such as a substrate). This method involves adding a sample containing the target to the DNA chip, and measuring the target by utilizing the property of the target being captured by the detection probe of the DNA chip through hybridization. This method can measure the amount of the target contained in the sample, in addition to determining whether the target is contained in the sample.
[0003] The following Patent Document 1 discloses a method for measuring a target using a nucleic acid sequence measuring device (DNA chip) provided with a fluorescent probe having a fluorescent molecule added thereto and a quenching probe having a quenching molecule added thereto that quenches the fluorescence of the fluorescent molecule as the above-mentioned detection probes. With this method, it is possible to measure the target without adding a fluorescent molecule to the target or washing the DNA chip (washing to remove uncaptured targets, etc.). [Prior art documents] [Patent documents]
[0004] [Patent Document 1] Patent No. 5928906 Summary of the Invention [Problem to be solved by the invention]
[0005] Incidentally, in a nucleic acid sequence measurement device, the amount of fluorescent light (spot light amount) emitted from a spot (measurement area) where a detection probe is provided may vary. For example, the spot light amount may vary between production lots, between devices within a production lot, between blocks (divided areas each consisting of a plurality of spots) within a device, and between spots within a block.
[0006] Such variation in the spot light intensity may reduce detection sensitivity or reliability due to false positives or false negatives. In addition, the spot light intensity of the nucleic acid sequence measurement device may change over time. Such changes in the spot light intensity may also reduce reliability due to false positives or false negatives.
[0007] The present invention has been made in consideration of the above-mentioned circumstances, and aims to provide a nucleic acid sequence measurement apparatus, a nucleic acid sequence measurement method, a nucleic acid sequence measurement program, and a nucleic acid sequence measurement device that can measure a target with higher reliability than conventional methods even if there is variation in the spot light intensity or change over time. [Means for solving the problem]
[0008] In order to solve the above problems, a nucleic acid sequence measuring device according to a first aspect of the present invention is a nucleic acid sequence measuring device (1) that measures a target (TG) having a specific nucleic acid sequence contained in a sample, and includes a detection unit (12) that detects fluorescence emitted from a nucleic acid sequence measuring device (DV) that is provided with a measurement area (SP1) that emits a first fluorescence upon reaction with the target and a reference area (SP2) that emits a second fluorescence regardless of reaction with the target, and a calculation unit (25) that measures the target based on the amount of light obtained by correcting or normalizing the amount of light of the first fluorescence emitted from the measurement area, out of the fluorescence detected by the detection unit, using the amount of light of the second fluorescence emitted from the reference area.
[0009] A nucleic acid sequence measuring apparatus according to a second aspect of the present invention is the nucleic acid sequence measuring apparatus according to the first aspect of the present invention, wherein the nucleic acid sequence measuring device is provided with a plurality of the measurement areas and a plurality of the reference areas, and the calculation unit corrects or normalizes the spatial distribution of the amount of light of the first fluorescence emitted from the plurality of the measurement areas using the amount of light of the second fluorescence emitted from the plurality of the reference areas.
[0010] A nucleic acid sequence measuring device according to a third aspect of the present invention is a nucleic acid sequence measuring device according to the second aspect of the present invention, wherein the calculation unit calculates a coefficient indicating a change in the amount of light of the second fluorescence along a straight line (LN2) passing through any two or more of the reference areas from the amount of light of the second fluorescence emitted from any two or more of the reference areas, and corrects the spatial distribution of the amount of light of the first fluorescence emitted from the measurement areas located on the straight line using the coefficient. A nucleic acid sequence measuring device according to a fourth aspect of the present invention is a nucleic acid sequence measuring device according to the third aspect of the present invention, wherein the coefficient is a coefficient indicating a rate of change of the amount of light of the second fluorescence along the straight line, or a coefficient based on multiple regression analysis or multivariate analysis of the amount of light of the second fluorescence along the straight line.
[0011] A nucleic acid sequence measuring device according to a fifth aspect of the present invention is a nucleic acid sequence measuring device according to the first aspect of the present invention, wherein the calculation unit uses information indicating the positions of the reference regions, information indicating the amount of light of the second fluorescence emitted from the reference regions, and information indicating the position of the measurement region as explanatory variables, and corrects the amount of light of the first fluorescence emitted from the measurement region using the correction coefficient obtained by substituting the explanatory variables into a learning model trained using a correction coefficient in the measurement region as an objective variable.
[0012] A nucleic acid sequence measuring device according to a sixth aspect of the present invention is the nucleic acid sequence measuring device according to the first aspect of the present invention, wherein the calculation unit corrects the amount of light of the first fluorescence emitted from the measurement area based on the amount of light of the second fluorescence emitted from the reference area using a relational equation showing the relationship between the change over time in the amount of light of the first fluorescence emitted from the measurement area and the change over time in the amount of light of the second fluorescence emitted from the reference area.
[0013] A nucleic acid sequence measuring device according to a seventh aspect of the present invention is a nucleic acid sequence measuring device according to any one of the first to sixth aspects of the present invention, wherein the calculation unit extracts the measurement area using a predetermined light intensity threshold (TH0) and corrects the light intensity threshold according to the light intensity of the second fluorescence emitted from the reference area.
[0014] A nucleic acid sequence measuring device according to an eighth aspect of the present invention is a nucleic acid sequence measuring device according to any one of the first to seventh aspects of the present invention, wherein the calculation unit reports an abnormality when the amount of light of the second fluorescence emitted from the reference region exceeds a preset upper threshold or lower threshold.
[0015] A nucleic acid sequence measuring apparatus according to a ninth aspect of the present invention is a nucleic acid sequence measuring apparatus according to any one of the first to eighth aspects of the present invention, wherein the measurement area and the reference area in the nucleic acid sequence measuring device are divided into partitioned areas (BK) each having a predetermined number as a unit, and the detection unit is provided with an image acquisition unit (12a) that acquires an image of the partitioned area.
[0016] A nucleic acid sequence measurement method according to one embodiment of the present invention is a nucleic acid sequence measurement method for measuring a target (TG) having a specific nucleic acid sequence contained in a sample, and includes a calculation step (S15, S16) of measuring the target based on the amount of light emitted from a nucleic acid sequence measurement device (DV) having a measurement area (SP1) that emits a first fluorescence upon reaction with the target and a reference area (SP2) that emits a second fluorescence regardless of reaction with the target, and of the fluorescence emitted from the measurement area, the amount of light of the first fluorescence emitted from the measurement area is corrected or normalized using the amount of light of the second fluorescence emitted from the reference area.
[0017] A nucleic acid sequence measurement program according to one embodiment of the present invention causes a computer to execute a calculation step (S15, S16) of measuring the target based on an amount of fluorescence emitted from a nucleic acid sequence measurement device (DV) having a measurement area (SP1) that emits a first fluorescence upon reaction with a target (TG) having a specific nucleic acid sequence contained in a sample, and a reference area (SP2) that emits a second fluorescence regardless of reaction with the target, the amount of the first fluorescence emitted from the measurement area being corrected or normalized using the amount of the second fluorescence emitted from the reference area.
[0018] A nucleic acid sequence measuring device according to a first aspect of the present invention is a nucleic acid sequence measuring device (DV) used to measure a target (TG) having a specific nucleic acid sequence contained in a sample, and is provided with a measurement region (SP1) that emits a first fluorescence upon reaction with the target, and a reference region (SP2) that emits a second fluorescence regardless of reaction with the target.
[0019] A nucleic acid sequence measuring device according to a second aspect of the present invention is a nucleic acid sequence measuring device according to the first aspect of the present invention, in which the measurement area and the reference area are divided into partition areas (BK) each having a predetermined number as a unit. Effect of the Invention
[0020] According to the present invention, there is an advantage that a target can be measured with higher reliability than in the past even if there is variation in the spot light amount or a change over time. [Brief description of the drawings]
[0021] [Figure 1] 1 is a perspective view showing a schematic external view of a nucleic acid sequence measuring device according to an embodiment of the present invention. [Diagram 2] FIG. 2 is a diagram showing a schematic diagram of a detection probe of a nucleic acid sequence measuring device used in an embodiment of the present invention. [Diagram 3] 1 is a block diagram showing a configuration of a main part of a nucleic acid sequence measuring apparatus according to an embodiment of the present invention. [Figure 4] 1 is a flowchart outlining a nucleic acid sequence measurement method according to an embodiment of the present invention. [Diagram 5] 1A to 1C are diagrams for explaining a spot extraction process performed in an embodiment of the present invention. [Figure 6] 11 is a flowchart showing a spatial correction process by normalization in units of blocks according to an embodiment of the present invention. [Figure 7] 11 is a flowchart showing a spatial correction process using a reference value in units of a block according to an embodiment of the present invention. [Figure 8] 11 is a flowchart showing a spatial correction process using an assumed reference value in units of a block according to an embodiment of the present invention. [Figure 9] 11A and 11B are diagrams for explaining a spatial correction process within a block when there is no reference value according to an embodiment of the present invention. [Figure 10] 11A and 11B are diagrams for explaining a space correction process using a reference value within a block according to an embodiment of the present invention. [Figure 11] FIG. 11 is a diagram showing an example of a change over time in the spot light amount. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0022] Hereinafter, a nucleic acid sequence measuring apparatus, a nucleic acid sequence measuring method, a nucleic acid sequence measuring program, and a nucleic acid sequence measuring device according to embodiments of the present invention will be described in detail with reference to the drawings. First, an overview of the embodiments of the present invention will be described, and then the details of the embodiments of the present invention will be described.
[0023] 〔overview〕 The embodiment of the present invention enables a target to be measured with higher reliability than before, even if there is variation or change over time in the spot light amount. Variations in the spot light amount may occur, for example, between manufacturing lots, between devices within a manufacturing lot, between blocks (divided areas each consisting of a plurality of spots) within a device, or between spots within a block. Changes over time in the spot light amount include, for example, a gradual decrease in the spot light amount as time passes.
[0024] Here, the nucleic acid sequence measuring device is manufactured through the following steps. First, a step of preparing a solution containing a detection probe to be used in the nucleic acid sequence measuring device is performed. Next, a step of dispensing the prepared solution in the form of spots on the substrate of the nucleic acid sequence measuring device (spotting) is performed using a dedicated spotter. Next, a step of evaporating the solvent of the spotted solution and binding and immobilizing the detection probe to the substrate is performed. Next, a step of blocking (blocking) is performed on the substrate to which the detection probe is not bound, among the binding molecules that bind the detection probe and the substrate. Then, a step of removing excess detection probe that is not immobilized on the substrate by washing is performed. The nucleic acid sequence measuring device manufactured through these steps is packaged and appropriately stored.
[0025] The following are considered to be causes of variation in the spot light intensity of the nucleic acid sequence measurement device. The following (1) to (7) are causes in the manufacturing process of the nucleic acid sequence measurement device. The following (8) and (9) are causes in the manufacturing process of the nucleic acid sequence measurement device and after the packaged nucleic acid sequence measurement device is opened.
[0026] (1) Variation in the binding molecules that bind the substrate of the nucleic acid sequence measurement device to the detection probe (2) Variation in the preparation of the solution containing the detection probe (3) Variation in the amount of spotter discharged during the spotting process (4) Uneven concentration of the detection probe due to evaporation of the solution during spotting (5) Uneven concentration of the detection probe due to evaporation of the solution during the immobilization process (6) Uneven binding between the binding molecule and the detection probe during the immobilization process (7) Uneven detachment of detection probes immobilized on the substrate during the blocking process, etc. (8) Fading of the detection probe fluorescent molecules and decomposition of the detection probe molecules due to exposure to environmental light (9) Uneven hydrolysis due to humidity
[0027] For example, if there is variation in the preparation of the spotting solution for each production lot, the spot light intensity will vary between production lots. Also, if there is variation in the discharge amount during spotting or uneven concentration of the detection probe, the spot light intensity will vary between blocks in a device or between spots within a block.
[0028] When such a variation in the spot light amount occurs, it is possible that reliability will decrease due to the occurrence of false positives or false negatives. In addition, it is possible that reliability will decrease due to the occurrence of false positives or false negatives due to changes in the spot light amount over time. In addition, if the spot light amount decreases significantly due to changes over time, it is possible that it will become impossible to identify the spot and perform measurement.
[0029] In an embodiment of the present invention, fluorescence is detected from a nucleic acid sequence measurement device having a measurement area that emits fluorescence upon reaction with a target having a specific nucleic acid sequence contained in a sample, and a reference area that emits fluorescence regardless of reaction with the target.The target is then measured based on the amount of detected fluorescence, which is corrected or normalized using the amount of fluorescence emitted from the measurement area, using the amount of fluorescence emitted from the reference area.As a result, even if there is variation or change over time in the spot light amount in the measurement area, the target can be measured with higher reliability than in the past.
[0030] [Embodiment] In the following, first, a nucleic acid sequence measurement device used for measuring a nucleic acid sequence will be described, followed by a nucleic acid sequence measurement apparatus, a nucleic acid sequence measurement method, and a nucleic acid sequence measurement program for measuring a nucleic acid sequence using the nucleic acid sequence measurement device.
[0031] <Nucleic acid sequence measurement device> FIG. 1 is a perspective view showing a schematic appearance of a nucleic acid sequence measuring device according to an embodiment of the present invention. In FIG. 1, a part of the nucleic acid sequence measuring device is enlarged and illustrated. As shown in FIG. 1, the nucleic acid sequence measuring device DV is, for example, a substrate SB on which a plurality of spots SP are formed. As the substrate SB, for example, plate-shaped glass formed into a rectangular shape in a planar view, silicon, single crystals such as calcium fluoride and sapphire, ceramics, and resin materials can be used. As the resin material, COP (cycloolefin polymer), which has excellent optical properties and chemical and thermal stability, COC (cyclic olefin copolymer), polycarbonate, acrylic resin, polyethylene resin, and the like can be used. In addition, the planar view shape of the substrate SB may be any shape.
[0032] The spot SP includes a detection probe spot SP1 (measurement region) and a marker spot SP2 (reference region). The detection probe spot SP1 is a region where a detection probe (described in detail below) used to detect a target to be measured is fixed. The marker spot SP2 is a region where a fluorescent probe (described in detail below) is fixed. The marker spot SP2 is provided to correct or normalize the variation in the spot light amount in the detection probe spot SP1.
[0033] The spots SP are divided into blocks BK (partitioned regions) each having a predetermined number as a unit. In the nucleic acid sequence measurement device DV shown in Fig. 1, a total of 672 spots SP are divided into 16 blocks BK, each of which has a total of 42 spots SP arranged in 6 rows and 7 columns as a unit. In the example shown in Fig. 1, six marker spots SP2 are arranged in the first column CL1 and the seventh column CL7 of each block BK, and six detection probe spots SP1 are arranged in the second column CL2 to the sixth column CL6 of each block BK.
[0034] The detection probe spots SP1 arranged in the second column CL2 to the sixth column CL6 in each block BK are, for example, arranged in the same column to collect the same target, while those arranged in different columns to collect different targets. All of the detection probe spots SP1 arranged in the second column CL2 to the sixth column CL6 may collect the same target. Alternatively, all of the detection probe spots SP1 arranged in the second column CL2 to the sixth column CL6 may collect different targets. The number of detection probe spots SP1 that collect the same target is arbitrary.
[0035] 1 shows an example in which the marker spots SP2 are arranged in the first column CL1 and the seventh column CL7 of each block BK, but the arrangement of the marker spots SP2 is not limited to this. For example, only one marker spot SP2 may be provided in each block BK, or multiple marker spots SP2 may be provided. Furthermore, the marker spots SP2 may be provided based on the substrate SB, may be provided based on the block BK, or may be provided based on a specific area within the block BK.
[0036] Addition of a sample to the nucleic acid sequence measuring device DV is performed for each block BK. Furthermore, image acquisition of the nucleic acid sequence measuring device DV is often performed for each block BK.
[0037] Fig. 2 is a schematic diagram showing a detection probe of a nucleic acid sequence measurement device used in an embodiment of the present invention. As shown in Fig. 2, the detection probe is composed of a fluorescent probe PB1 and a quenching probe PB2 fixed on a substrate SB. The fluorescent probe PB1 has a fluorescent molecule FM added to a complementary sequence of the target TG to be measured. The quenching probe PB2 has a quenching molecule QM added to a sequence that is at least partially complementary to the complementary sequence of the fluorescent probe PB1.
[0038] The target TG is not particularly limited as long as it is an object to be detected in a sample, and examples thereof include nucleic acids such as DNA and RNA, peptides, and proteins. Examples of capture molecules that specifically bind to the target TG include detection probes that hybridize with nucleic acids, antibodies or antibody fragments that specifically bind to antigens such as peptides and proteins, and aptamers that specifically bind to nucleic acids. As the above-mentioned antibody, either a polyclonal antibody or a monoclonal antibody can be used, but a monoclonal antibody is preferred. Examples of antibody fragments include F(ab')2, F(ab)2, Fab', Fab, Fv, scFv, mutants thereof, fusion proteins or fusion peptides containing an antibody portion, and the like. In addition, the target may be an antibody or an antibody fragment, and the capture molecule may be an antigen such as a peptide or protein that specifically binds to the antibody or antibody fragment.
[0039] The fluorescent molecule FM is not particularly limited as long as it is a molecule that emits fluorescence when excited by specific excitation light, and examples of such molecules include the Alexa Fluor (registered trademark) series, ATTO series, Brilliant series, Chromeo (registered trademark) series, Bacteriochlorin series, FAM, TAMRA, Cy dye series, FITC, HiLyte Fluor (registered trademark) series, Rhodamine series, Tide Fluor (registered trademark) series, iFluor (registered trademark) series, DY dye series, B-Phycoerythrin, R-Phycoerythrin, APC, Qdot, and PID fluorescent nanoparticles.
[0040] The fluorescent probe PB1 and the quencher probe PB2 are bonded together so that the fluorescence of the fluorescent molecule FM is quenched by the quencher molecule QM. In the example shown in Fig. 2, the fluorescent probe PB1 and the quencher probe PB2 are bonded together at the binding site CN. Here, the fluorescence of the fluorescent molecule FM is quenched by the quencher molecule QM according to the principle of quenching by fluorescence resonance energy transfer.
[0041] In the absence of target TG, the fluorescent probe PB1 and the quencher probe PB2 are bound at the binding site CN, and the fluorescent molecule FM and the quencher molecule QM are in close proximity. In this state, even when excitation light is irradiated, the fluorescence of the fluorescent molecule FM is quenched by the quencher molecule QM, so no fluorescence is emitted.
[0042] In contrast, when the target TG is present, the fluorescent probe PB1, which has a complementary sequence to the target TG, dissociates from the quenching probe PB2 and binds to the target TG, as shown in Figure 2. When the target TG binds to the fluorescent probe PB1, the binding between the fluorescent probe PB1 and the quenching probe PB2 is eliminated, and the fluorescent molecule FM and the quenching molecule QM are separated from each other. In this state, the fluorescent molecule FM emits fluorescence when irradiated with excitation light.
[0043] The complementary sequence of the target TG may be provided in the quenching probe PB2. That is, the quenching probe PB2 may be a probe in which a quenching molecule QM is added to the complementary sequence of the target TG, and the fluorescent probe PB1 may be a probe in which a fluorescent molecule FM is added to a sequence at least partially complementary to the complementary sequence of the quenching probe PB2.
[0044] A detection probe having a fluorescent probe PB1 and a quenching probe PB2 bound thereto is fixed to the detection probe spot SP1 shown in Fig. 1. Therefore, the detection probe spot SP1 emits fluorescence (first fluorescence) by reacting with the target TG. In contrast, the quenching probe PB2 is not fixed to the marker spot SP2 shown in Fig. 1, and only the fluorescent probe PB1 is fixed thereto. Therefore, the marker spot SP2 emits fluorescence (second fluorescence) regardless of whether or not it reacts with the target TG.
[0045] <Nucleic acid sequence measuring device> Fig. 3 is a block diagram showing the main components of a nucleic acid sequence measuring device according to an embodiment of the present invention. As shown in Fig. 3, a nucleic acid sequence measuring device 1 according to this embodiment includes a detection device 10 and a calculation device 20, and measures a target TG contained in a sample using a nucleic acid sequence measuring device DV described with reference to Figs.
[0046] The detection apparatus 10 includes a stage 11 and a detection unit 12, and detects fluorescence emitted from a nucleic acid sequence measuring device DV. The stage 11 is configured so that a nucleic acid sequence measuring device DV can be placed thereon. The stage 11 is preferably provided with a function for adjusting the temperature of the placed nucleic acid sequence measuring device DV, and is preferably configured so that the sample can be stirred by vibrating or rotating the nucleic acid sequence measuring device DV.
[0047] The detection unit 12 irradiates the nucleic acid sequence measuring device DV with excitation light and detects fluorescence emitted from the nucleic acid sequence measuring device DV. The detection unit 12 includes an excitation light source (not shown) and an image acquisition unit 12a. The excitation light source (not shown) emits excitation light to be irradiated onto the nucleic acid sequence measuring device DV. The excitation light emitted from the excitation light source is irradiated, for example, for each block BK shown in FIG. 1. As the excitation light source (not shown), for example, a laser light source that emits a single-wavelength laser light or its expanded light, an LED (Light Emitting Diode), a lamp that emits white light, a light source formed by a combination of an LED and a wavelength filter, etc. can be used.
[0048] The image acquiring unit 12a includes a solid-state image sensor such as a CCD (Charge Coupled Device) or a CMOS (Complementary Metal Oxide Semiconductor) and acquires an image (two-dimensional image) of the nucleic acid sequence measuring device DV. The image acquiring unit 12a acquires an image for each block BK shown in FIG.
[0049] The calculation device 20 measures the target TG based on the detection result of the detection device 10. Specifically, the calculation device 20 measures the amount of the target contained in the sample in addition to determining whether the target TG is contained in the sample added to the nucleic acid sequence measurement device DV. The calculation device 20 includes an operation unit 21, a display unit 22, an input / output unit 23, a storage unit 24, and a calculation unit 25.
[0050] The operation unit 21 includes an input device such as a keyboard or a pointing device, and outputs instructions (instructions for the arithmetic unit 20) according to operations by a user who uses the arithmetic unit 20 to the arithmetic unit 25. The display unit 22 includes a display device such as a liquid crystal display device, and displays various information output from the arithmetic unit 25. The operation unit 21 and the display unit 22 may be physically separated, or may be physically integrated, such as a touch panel type liquid crystal display device that has both a display function and an operation function.
[0051] The input / output unit 23 is connected to the detection unit 12 of the detection device 10, and inputs and outputs various data between the detection unit 12. For example, the input / output unit 23 outputs control data for causing an excitation light source (not shown) to be emitted from the detection unit 12 to the detection unit 12. The input / output unit 23 also outputs control data for detection to the detection unit 12, receives detection results (image data acquired by the image acquisition unit 12a), and outputs the detection results to the calculation unit 25.
[0052] The storage unit 24 includes an auxiliary storage device such as an HDD (hard disk drive) or an SSD (solid state drive), and stores various data. For example, the storage unit 24 stores image data output from the detection unit 12, various data required for the calculation of the calculation unit 25, data indicating the calculation results of the calculation unit 25, and other data. The storage unit 24 may store, for example, a program that realizes the function of the calculation unit 25.
[0053] The calculation unit 25 stores the image data output from the input / output unit 23 in the storage unit 24. The calculation unit 25 also reads out the image data stored in the storage unit 24, processes the image data, and measures the target TG contained in the sample added to the nucleic acid sequence measurement device DV. Specifically, after hybridization, the calculation unit 25 corrects or normalizes the spot light intensity of the detection probe spot SP1 in the block BK of the nucleic acid sequence measurement device DV using the spot light intensity of the marker spot SP2. Then, the calculation unit 25 measures the target TG based on the corrected or normalized spot light intensity. Details of the processing performed by the calculation unit 25 will be described later.
[0054] The functions of the calculation unit 25 may be realized in software, for example, by a CPU (Central Processing Unit) or an MPU (Micro Processing Unit) reading and executing a program stored in the storage unit 24. Alternatively, the functions of the calculation unit 25 may be realized using hardware such as an FPGA (Field Programmable Gate Array), an LSI (Large Scale Integration), or an ASIC (Application Specific Integrated Circuit).
[0055] <Nucleic Acid Sequence Measurement Method> Fig. 4 is a flowchart showing an outline of a nucleic acid sequence measuring method according to an embodiment of the present invention. Before the process of the flowchart shown in Fig. 4 is started, a sample containing a target TG is prepared. In addition, an operation is performed to prepare the nucleic acid sequence measuring device DV described with reference to Figs. 1 and 2 on the stage 11 of the nucleic acid sequence measuring apparatus 1. When the above preparations and operations are completed, for example, a sample is added to one of the multiple blocks BK of the nucleic acid sequence measuring device DV (hereinafter referred to as "target block BK0").
[0056] When a sample is added to the nucleic acid sequence measuring device DV, first, the detection unit 12 performs a process of acquiring an image after the sample is added (step S11: detection step). Specifically, after a time has elapsed when hybridization is considered to have progressed sufficiently, a process of acquiring an image of the target block BK0 by the image acquisition unit 12a is performed. The image acquired in step S11 is output from the detection unit 12 to the calculation device 20. The image output from the detection unit 12 to the calculation device 20 is stored in the storage unit 24 of the calculation device 20.
[0057] Here, the time when hybridization is considered to have progressed sufficiently varies depending on the properties of the nucleic acid sequence measuring device DV (properties of the fluorescent probe PB1 and the quenching probe PB2) and the amount of target TG contained in the sample. For this reason, it is desirable to determine the above-mentioned time in advance, for example, by performing an experiment in advance.
[0058] Next, the image stored in the storage unit 24 is read out, image-processed, and the spot is extracted by the calculation unit 25 of the calculation device 20 (step S12: detection step). Specifically, image processing is performed on the image acquired in step S11 (image of the target block BK0) to extract the spot area (area estimated to be the image of the spot SP).
[0059] FIG. 5 is a diagram for explaining the spot extraction process performed in an embodiment of the present invention. FIG. 5(a) is a diagram showing an image of one detection probe spot SP1 and its surroundings, and FIG. 5(b) is a diagram showing the light amount distribution along the line LN1 in FIG. 5(a). Fluorescence is emitted from the detection probe spot SP1 in the target block BK0. Therefore, as shown in FIG. 5(a), the image of the detection probe spot SP1 is brighter than the surroundings of the detection probe spot SP1. In addition, as shown in FIG. 5(b), the light amount distribution along the line LN1 in FIG. 5(a) is higher inside the detection probe spot SP1 and lower outside the detection probe spot SP1.
[0060] As shown in FIG. 5(b), outside the detection probe spot SP1, there exists a background (background light) light amount BG and background noise. If the amount of fluorescent light emitted from the detection probe spot SP1 is approximately the same as the background light amount BG, the detection probe spot SP1 cannot be extracted. In this embodiment, a threshold value TH0 (light amount threshold) is set to a light amount greater than the background light amount BG. The calculation unit 25 of the calculation device 20 performs a process of extracting an area from which a light amount exceeding the threshold value TH0 is emitted as the detection probe spot SP1. Here, an example of extracting the detection probe spot SP1 has been described, but the marker spot SP2 can also be extracted by a similar process.
[0061] Next, the calculation unit 25 of the calculation device 20 performs a process of calculating the light amount of the detection probe spot SP1 (step S13: detection step). Specifically, the spot area extracted in step S12 is sorted into an area of the detection probe spot SP1 and an area of the marker spot SP2 based on the position in the imaged target block BK0. Then, for each of the selected areas of the detection probe spot SP1, a process is performed to obtain the average grayscale value of each pixel forming the image of the detection probe spot SP1 as the light amount of the detection probe spot SP1.
[0062] Further, the calculation unit 25 of the calculation device 20 performs a process of calculating the light amount of the marker spot SP2 (step S14: detection step). Specifically, for each of the regions of the marker spot SP2 selected in the process of step S13, a process is performed to obtain the average gradation value of each pixel constituting the image of the marker spot SP2 as the light amount of the marker spot SP2. Note that, in FIG. 4, the process of step S13 and the process of step S14 are separated for ease of understanding, but these processes may be performed simultaneously.
[0063] Next, the calculation unit 25 of the calculation device 20 performs a process of standardizing or correcting the amount of light of the detection probe spot SP1 using the amount of light of the marker spot SP2 (step S15: calculation step). For example, the calculation unit 25 corrects or standardizes the spatial distribution of the amount of fluorescence emitted from the multiple detection probe spots SP1 provided in the target block BK0 using the amount of fluorescence emitted from the multiple marker spots SP2 provided in the target block BK0. Note that there are several processes for standardizing or correcting the amount of light of the detection probe spot SP1 using the amount of light of the marker spot SP2, so the details of the process of step S15 will be described later.
[0064] When the above processes are completed, the calculation unit 25 of the calculation device 20 performs a process of measuring the target TG contained in the sample (step S16: calculation step). Specifically, the calculation unit 25 determines whether or not the sample added to the nucleic acid sequence measurement device DV contains the target TG. In addition, the amount of the target contained in the sample is measured by the calculation unit 25 based on the normalized or corrected light amount of the detection probe spot SP1. In this manner, the target TG contained in the sample is measured.
[0065] <Processing of Step S15> The process of step S15 shown in Fig. 4 is roughly divided into a process for normalizing or correcting spatial variations in the spot light quantity (hereinafter referred to as spatial correction process) and a process for normalizing or correcting changes over time in the spot light quantity (hereinafter referred to as temporal correction process). Below, these spatial correction process and temporal correction process will be described in order.
[0066] "Spatial Correction Processing" The spatial variation in the spot light amount may occur, for example, between manufacturing lots, between devices DV for measuring nucleic acid sequences within a manufacturing lot, between blocks BK within a device DV for measuring nucleic acid sequences, and between spots SP within a block BK. In the following, the spatial correction process in units of a block BK and the spatial correction process within a block BK will be described as examples.
[0067] Spatial correction processing in units of blocks (BK) (a) Spatial correction by normalization 6 is a flowchart showing a spatial correction process by normalization in units of blocks in an embodiment of the present invention. When the process is started, first, a process of calculating an average value of the light intensity of the marker spots SP2 is performed by the calculation unit 25 of the calculation device 20 (step S21). Specifically, a process of calculating an average value of the light intensity of a total of 12 marker spots SP2 in the target block BK0 calculated in step S14 shown in FIG. 4 is performed. The total of 12 marker spots SP2 in the target block BK0 are the marker spots SP2 arranged in the first column CL1 and the seventh column CL7 of the block BK shown in FIG. 1.
[0068] Next, the calculation unit 25 of the calculation device 20 performs a process of dividing each of the light intensities of the detection probe spots SP1 by the average light intensities of the marker spots SP2 (step S22). Specifically, a process of dividing each of the light intensities of the total 30 detection probe spots SP1 in the target block BK0 calculated in step S13 shown in FIG. 4 by the average light intensities of the marker spots SP2 is performed. The total 30 detection probe spots SP1 in the target block BK0 are the detection probe spots SP1 arranged in the second column CL2 to the sixth column CL6 of the block BK shown in FIG. 1. By performing this process, the light intensities of each of the detection probe spots SP1 are normalized by the average light intensities of the marker spots SP2.
[0069] 4, the calculation unit 25 of the calculation device 20 performs a process of measuring the target TG contained in the sample based on the normalized light amount of the detection probe spot SP1. In this process, a determination threshold (hereinafter, referred to as a first determination threshold) set for the space correction process by normalization is used to determine whether or not the target TG is contained in the sample added to the nucleic acid sequence measurement device DV.
[0070] (b) Spatial correction process using reference values FIG. 7 is a flowchart showing a space correction process using a reference value in units of blocks in an embodiment of the present invention. Here, the reference value is a value indicating a reference light amount of the marker spot SP2 of the nucleic acid sequence measuring device DV. This reference value is, for example, an average value or a median value of the light amount of the marker spot SP2 obtained in a state (wet state) in which a sample is added to the nucleic acid sequence measuring device DV manufactured in advance in a plurality of manufacturing lots and hybridization is performed. Note that, when calculating the reference value, it is desirable to use the light amount of the obtained marker spot SP2 excluding those with a significantly different light amount (outliers). Note that the reference value is, for example, stored in advance in the storage unit 24 of the calculation device 20 in the nucleic acid sequence measuring device 1 shown in FIG. 3.
[0071] 7 is started, first, the calculation unit 25 of the calculation device 20 calculates the average light amount of the marker spot SP2 (step S31). Specifically, similar to the process of step S21 shown in FIG. 6, the calculation unit 25 calculates the average light amount of the 12 marker spots SP2 in the target block BK0.
[0072] Next, the calculation unit 25 of the calculation device 20 calculates a correction coefficient indicating the deviation between the average value of the light amount of the marker spot SP2 and a reference value (step S32). Specifically, the correction coefficient is calculated by dividing the average value of the light amount of the marker spot SP2 calculated in step S31 by the reference value.
[0073] Next, a process is performed in which the light intensities of the 30 detection probe spots SP1 in the target block BK0 calculated in step S13 shown in Fig. 4 are multiplied by the correction coefficient calculated in step S32 (step S33). By performing this process, the light intensities of the detection probe spots SP1 are corrected using the correction coefficient indicating the deviation between the average value of the light intensities of the marker spots SP2 and the reference value.
[0074] When the above process is completed, in step S16 shown in Fig. 4, the calculation unit 25 of the calculation device 20 performs a process of measuring the target TG contained in the sample based on the corrected light intensity of the detection probe spot SP1. In this process, a judgment threshold set for the spatial correction process using a reference value is used to judge whether or not the target TG is contained in the sample added to the nucleic acid sequence measurement device DV. Note that the judgment threshold set for the spatial correction process using the reference value (hereinafter referred to as the second judgment threshold) is different from the above-mentioned first judgment threshold.
[0075] (c) Spatial correction process using assumed reference values 8 is a flowchart showing a space correction process using an assumed reference value in units of blocks in an embodiment of the present invention. Here, the assumed reference value is a value indicating the reference light amount of the marker spot SP2 of the nucleic acid sequence measuring device DV, similar to the above-mentioned reference value. However, the difference is that the above-mentioned reference value is a value obtained in advance, whereas the assumed reference value is a value calculated each time the nucleic acid sequence measuring device DV is used.
[0076] When the assumed reference value is used, for example, a ratio (hereinafter, referred to as a state correction value) between the average value or median value of the light intensity of the marker spots SP2 obtained in a state (dry state) without adding a sample to the nucleic acid sequence measuring device DV manufactured in advance in multiple production lots and the average value or median value of the light intensity of the marker spots SP2 obtained in a wet state is calculated in advance. Note that this state correction value is, for example, stored in advance in the storage unit 24 of the calculation device 20 in the nucleic acid sequence measuring device 1 shown in FIG.
[0077] In addition, for each nucleic acid sequence measuring device DV to be shipped, the light amount of the marker spot SP2 is obtained in a dry state, and the average value or median value of the obtained light amount (hereinafter referred to as dry value) is obtained. Note that since the light amount of the marker spot SP2 in a dry state can be obtained without destroying the nucleic acid sequence measuring device DV, the nucleic acid sequence measuring device DV in which the light amount of the marker spot SP2 has been obtained can be shipped. The dry value obtained for each nucleic acid sequence measuring device DV is associated with, for example, the identifier of the nucleic acid sequence measuring device DV, and is stored in advance in the storage unit 24 of the calculation device 20 in the nucleic acid sequence measuring device 1 shown in FIG. 3. The dry value may be stored in an electronic tag attached to the nucleic acid sequence measuring device DV to be shipped, or may be printed as a barcode on a tag attached to the nucleic acid sequence measuring device DV to be shipped.
[0078] 8 is started, first, a process of calculating an assumed reference value is performed by the calculation unit 25 of the calculation device 20 (step S41). Specifically, for example, the state correction value stored in the storage unit 24 and the dry value of the nucleic acid sequence measurement device DV mounted on the stage 11 are read from the storage unit 24, and the read state correction value and the dry value are multiplied to calculate the assumed reference value. The assumed reference value can also be said to be a value indicating a reference light amount of the marker spot SP2 in a wet state, which is assumed from the light amount of the marker spot SP2 obtained in a dry state.
[0079] Next, a process of calculating an average value of the light amounts of the marker spots SP2 is performed by the calculation unit 25 of the calculation device 20 (step S42). Specifically, similar to the processes of step S21 shown in Fig. 6 and step S31 shown in Fig. 7, a process of calculating an average value of the light amounts of the total 12 marker spots SP2 in the target block BK0 is performed.
[0080] Next, the calculation unit 25 of the calculation device 20 calculates a correction coefficient indicating the deviation between the average value of the light amount of the marker spot SP2 and the assumed reference value (step S43). Specifically, the correction coefficient is calculated by dividing the average value of the light amount of the marker spot SP2 calculated in step S42 by the assumed reference value.
[0081] Then, a process is performed (step S44) in which the light intensities of the total 30 detection probe spots SP1 in the target block BK0 calculated in step S13 shown in Fig. 4 are multiplied by the correction coefficient calculated in step S43. By performing this process, the light intensities of the detection probe spots SP1 are corrected using the correction coefficient indicating the deviation between the average light intensities of the marker spots SP2 and the assumed reference value.
[0082] 4, the calculation unit 25 of the calculation device 20 performs a process of measuring the target TG contained in the sample based on the corrected light intensity of the detection probe spot SP1. In this process, it is determined whether or not the target TG is contained in the sample added to the nucleic acid sequence measurement device DV by using a determination threshold similar to the above-mentioned second determination threshold.
[0083] As described above, the expected reference value is calculated for each device DV for measuring nucleic acid sequences using the previously obtained state correction value and the dry value of the device DV for measuring nucleic acid sequences. This makes it possible to correct each device DV for measuring nucleic acid sequences even if the manufacturing variation of the device DV for measuring nucleic acid sequences is large and cannot be fully corrected by the above-mentioned reference value.
[0084] Spatial correction processing within block BK The spatial correction process in the block BK is basically performed using the amount of fluorescent light emitted from any two or more of the marker spots SP2 in the block BK (target block BK0). Specifically, a coefficient indicating the change in the amount of fluorescent light along a straight line passing through any two or more marker spots SP2 in the block BK (target block BK0) is obtained, and the spatial distribution of the amount of fluorescent light emitted from the detection probe spots SP1 located on that straight line is corrected using the coefficient.
[0085] Here, the coefficient may be a coefficient indicating a rate of change in the amount of fluorescent light emitted from the marker spot SP2 along the straight line, or may be a coefficient based on multiple regression analysis or multivariate analysis of the amount of fluorescent light emitted from the marker spot SP2 along the straight line.
[0086] In addition, when performing correction using coefficients based on multiple regression analysis, for example, the marker spot light amount at any coordinate in the image of the target block BK0 is set as the objective variable y, the horizontal coordinate in the image is set as the explanatory variable x1, and the vertical coordinate in the image is set as the explanatory variable x2. Then, partial regression coefficients α1 and α2 of the explanatory variables x1 and x2 and constant C are obtained from multiple marker spot light amounts. A predicted value of the marker spot light amount y can be calculated by substituting any coordinate into the following formula (1). The spot light amount can be corrected using the light amount ratio between this predicted value of the marker spot light amount and the above-mentioned reference value as a coefficient. y = α1 x1 + α2 x2 + C … (1) A specific example of the spatial correction process will be described below.
[0087] (a) Spatial correction process when no reference value is available Fig. 9 is a diagram for explaining the spatial correction process in a block when there is no reference value in the embodiment of the present invention. Fig. 9(a) is a diagram showing the positional relationship of spots in a block BK (target block BK0), and Fig. 9(b) is a diagram showing the light intensity of the spots shown in Fig. 9(a). Note that Fig. 9 shows only three spots SP arranged on a straight line LN2 extending in the row direction out of the multiple spots SP arranged in the block BK shown in Fig. 1.
[0088] In Fig. 9(a), the marker spots SP2 arranged in the first row CL1 of the block BK shown in Fig. 1 are illustrated as marker spots SPa, and the marker spots SP2 arranged in the seventh row CL7 are illustrated as marker spots SPb. Also, one of the detection probe spots SP1 arranged in the second row CL2 to the sixth row CL6 of the block BK shown in Fig. 1 is illustrated as a detection probe spot SPx. Also, the distance between the marker spot SPa and the marker spot SPb is L, the distance between the marker spot SPa and the detection probe spot SPx is L1, and the distance between the detection probe spot SPx and the marker spot SPb is L2.
[0089] 9(b), the amount of light obtained from the marker spot SPa arranged on the straight line LN2 is Am1, and the amount of light obtained from the marker spot SPb is Am2. Also, the amount of light obtained from the detection probe spot SPx is As. The calculation unit 25 of the calculation device 20 calculates the amount of light Rs by linearly correcting the amount of light As obtained from the detection probe spot SPx based on the following formula (2). Rs=(L2×(As / Am1)+L1×(As / Am2)) / L…(2)
[0090] That is, the calculation unit 25 obtains a ratio between the light amount As of the detection probe spot SPx and the light amount Am1 of the marker spot SPa, and a ratio between the light amount As of the detection probe spot SPx and the light amount Am2 of the marker spot SPb. Then, the calculation unit 25 obtains a linearly corrected light amount Rs by weighting the obtained light amount ratios according to the positional relationship between the detection probe spot SPx and the marker spots SPa and SPb.
[0091] 4, the calculation unit 25 of the calculation device 20 performs a process of measuring the target TG contained in the sample based on the linearly corrected light amount of the detection probe spot SP1. In this process, a determination is made as to whether or not the target TG is contained in the sample added to the nucleic acid sequence measurement device DV using a determination threshold similar to the above-mentioned first determination threshold.
[0092] The calculation unit 25 may calculate the light amount of a virtual marker spot by assuming that the virtual marker spot is located at the position of the detection probe spot SPx shown in Fig. 9(a), and may correct the light amount of the detection probe spot SPx using the calculated light amount of the virtual marker spot to obtain the light amount Rs. The light amount Amx of the virtual marker spot at the position of the detection probe spot SPx is calculated using the following formula (3). Amx=(L2×Am1+L1×Am2) / L…(3) The amount of light Rs is calculated using the following formula (4). Rs=As / Amx=(As×L) / (L2×Am1+L1×Am2) …(4)
[0093] (b) Spatial correction process using reference values Fig. 10 is a diagram for explaining a space correction process using a reference value in a block in an embodiment of the present invention. Fig. 10(a) is a diagram showing the positional relationship of spots in a block BK (target block BK0), Fig. 10(b) is a diagram showing the light amount of the spot shown in Fig. 10(a), and Fig. 10(c) is a diagram showing the light amount of the spot after correction. Note that Fig. 10(a) is a diagram similar to Fig. 9(a), and Fig. 10(b) is a diagram similar to Fig. 9(b). However, in Fig. 10(b), the reference value is illustrated as ST.
[0094] The ratio between the reference value ST and the light amount Am1 of the marker spot SPa is k1, and the ratio between the reference value ST and the light amount Am2 of the marker spot SPb is k2. In other words, k1=ST / Am1, and k2=ST / Am2. The calculation unit 25 of the calculation device 20 obtains the light amount Rs by linearly correcting the light amount As obtained from the detection probe spot SPx based on the following formula (5). Rs=As×(k1+(L1 / L)×(k2-k1)…(5)
[0095] 10(c), the calculation unit 25 of the calculation device 20 calculates a correction coefficient for correcting the light amount Am1 of the marker spot SPa arranged on the straight line LN2 to the reference value ST and the light amount Am2 of the marker spot SPb to the reference value ST. Then, the calculation unit 25 uses the correction coefficient to linearly correct the light amount As of the detection probe spot SPx according to the positional relationship between the detection probe spot SPx and the marker spots SPa and SPb to calculate the light amount Rs.
[0096] 4, the calculation unit 25 of the calculation device 20 performs a process of measuring the target TG contained in the sample based on the linearly corrected light amount of the detection probe spot SP1. In this process, a determination is made as to whether or not the target TG is contained in the sample added to the nucleic acid sequence measurement device DV using a determination threshold similar to the above-mentioned second determination threshold.
[0097] The spatial correction process in the block BK is not limited to the above-mentioned "spatial correction process without a reference value" and "spatial correction process using a reference value". The calculation unit 25 may obtain a coefficient indicating a change in the amount of fluorescence light along a straight line passing through any two or more marker spots SP2 from the amount of fluorescence light emitted from any two or more marker spots SP2 among the multiple marker spots SP2, and may correct the spatial distribution of the amount of fluorescence light emitted from the detection probe spot SP1 located on the straight line using the above-mentioned coefficient. Alternatively, the calculation unit 25 may obtain a coefficient indicating a change in the amount of fluorescence light in the block BK from the amount of fluorescence light emitted from any three or more marker spots SP2 among the multiple marker spots SP2, and may correct the spatial distribution of the amount of fluorescence light emitted from any detection probe spot SP1 located in the block BK using the above-mentioned coefficient.
[0098] (c) Spatial correction process using a learning model The calculation unit 25 of the calculation device 20 may correct the amount of fluorescence light emitted from the detection probe spot SP1 using, for example, a learning model generated by machine learning. Here, the above learning model is a model trained using information indicating the positions of the detection probe spot SP1 and the marker spot SP2 in the image of the target block BK0 and information indicating the amount of light of the marker spot SP2 as explanatory variables, and a correction coefficient for the detection probe spot SP1 as a response variable. The calculation unit 25 of the calculation device 20 corrects the amount of fluorescence light emitted from the detection probe spot SP1 using a correction coefficient obtained by substituting the explanatory variables into the above learning model.
[0099] <Aging correction process> (a) Temporal correction process by normalization In the time-dependent correction process by normalization, the same process as that in the flowchart shown in Fig. 6 is performed. Therefore, the following description will be given with reference to Fig. 6. When the process is started, first, the calculation unit 25 of the calculation device 20 calculates the average value of the light intensities of the marker spots SP2 (step S21). Specifically, the process calculates the average value of the light intensities of the total of 12 marker spots SP2 in the target block BK0 calculated in step S14 shown in Fig. 4.
[0100] Next, the calculation unit 25 of the calculation device 20 performs a process of dividing each of the light intensities of the detection probe spots SP1 by the average value of the light intensities of the marker spots SP2 (step S22). Specifically, a process is performed in which each of the light intensities of the total 30 detection probe spots SP1 in the target block BK0 calculated in step S13 shown in Fig. 4 is divided by the average value of the light intensities of the marker spots SP2. This process normalizes the light intensities of the detection probe spots SP1 that have changed over time by the average value of the light intensities of the marker spots SP2 that have changed over time, so that the light intensities of the detection probe spots SP1 that have changed over time are ultimately corrected.
[0101] 4, the calculation unit 25 of the calculation device 20 performs a process of measuring the target TG contained in the sample based on the normalized light amount of the detection probe spot SP1. In this process, a determination is made as to whether or not the target TG is contained in the sample added to the nucleic acid sequence measurement device DV using a determination threshold similar to the above-mentioned first determination threshold.
[0102] (b) Time-dependent correction process using regression equation Fig. 11 is a diagram showing an example of the change over time in the spot light intensity. In the graph shown in Fig. 11, the horizontal axis represents the storage period (time) of the nucleic acid sequence measuring device DV, and the vertical axis represents the spot light intensity. In Fig. 11, curve L10 is a curve showing the change over time in the average value of the light intensity of the marker spot SP2 in the target block BK0, and curves L11 to L13 are curves showing the change over time in the light intensity of the detection probe spot SP1 in the target block BK0. As shown in Fig. 11, the change over time in the light intensity of the detection probe spot SP1 may differ depending on the type of the detection probe spot SP1.
[0103] For this reason, data showing the change over time in the light intensity of the detection probe spot SP1 and the light intensity of the marker spot SP2 is obtained in advance for each type of detection probe spot SP1. Then, a regression coefficient is calculated by simple regression analysis of the light intensity of the detection probe spot SP1 and the light intensity of the marker spot SP2 by the least squares method, and the degradation coefficient A is determined. This degradation coefficient A is stored in advance, for example, in the storage unit 24 of the calculation device 20 in the nucleic acid sequence measuring device 1 shown in FIG. 3. Note that the method of calculating the degradation coefficient A is not limited to simple regression analysis. For example, it may be calculated by inverse proportion, exponential approximation, or logarithmic approximation.
[0104] In the time-dependent correction process using the regression equation, the same process as that of the flowchart shown in Fig. 6 is performed. For this reason, the following description will be given with reference to Fig. 6. When the process is started, first, the calculation unit 25 of the calculation device 20 calculates the average value of the light intensities of the marker spots SP2 (step S21). Specifically, the process calculates the average value of the light intensities of the total of 12 marker spots SP2 in the target block BK0 calculated in step S14 shown in Fig. 4.
[0105] Next, the calculation unit 25 of the calculation device 20 divides each of the light intensities of the detection probe spots SP1 by the average light intensities of the marker spots SP2 (step S22). Specifically, the calculation unit 25 divides each of the light intensities of the 30 detection probe spots SP1 in the target block BK0 calculated in step S13 shown in Fig. 4 by the average light intensities of the marker spots SP2. The value obtained by the division is then multiplied by the deterioration coefficient A to correct the light intensities of the detection probe spots SP1 that have changed over time.
[0106] 4, the calculation unit 25 of the calculation device 20 performs a process of measuring the target TG contained in the sample based on the normalized light amount of the detection probe spot SP1. In this process, a determination is made as to whether or not the target TG is contained in the sample added to the nucleic acid sequence measurement device DV using a determination threshold similar to the above-mentioned first determination threshold.
[0107] As described above, in this embodiment, the fluorescence emitted from the nucleic acid sequence measurement device DV is provided with the detection probe spot SP1 that emits fluorescence upon reaction with the target TG having a specific nucleic acid sequence contained in the sample, and the marker spot SP2 that emits fluorescence regardless of reaction with the target TG. Then, the target TG is measured based on the amount of light of the detected fluorescence, which is corrected or normalized using the amount of light of the fluorescence emitted from the marker spot SP2. Therefore, even if there is variation or change over time in the spot light amount in the detection probe spot SP1, the target TG can be measured with higher reliability than before.
[0108] Although the nucleic acid sequence measurement apparatus, the nucleic acid sequence measurement method, the nucleic acid sequence measurement program, and the nucleic acid sequence measurement device according to the embodiments of the present invention have been described above, the present invention is not limited to the above-mentioned embodiments and can be freely modified within the scope of the present invention. For example, the image acquisition unit 12a described in the above-mentioned embodiments may acquire a monochrome two-dimensional image or a color two-dimensional image.
[0109] Furthermore, the image acquiring unit 12a may include a highly sensitive EMCCD (Electron Multiplying CCD) or a digital CMOS, other than a CCD or CMOS. Furthermore, the detection unit 12 may include a photodiode arranged in a one-to-one correspondence with the spot SP, instead of the image acquiring unit 12a (or together with the image acquiring unit 12a).
[0110] In addition, the threshold value used in step S13 shown in Fig. 4 may be changed, or an abnormality diagnosis may be performed on the nucleic acid sequence measurement device DV. Details of these will be described below in order.
[0111] <Changing the threshold value used in step S13> As explained with reference to Fig. 5, the spot area is extracted using a threshold TH0 (light amount threshold) that is set to a light amount greater than the background light amount BG. If the spot light amount changes over time, the spot light amount may become equal to or smaller than the threshold TH0, resulting in an error in extracting the spot area.
[0112] Here, the light amount of the marker spot SP2 is greater than that of the detection probe spot SP1. Therefore, the threshold value TH0 is corrected based on the change over time in the light amount of the marker spot SP2 to prevent an extraction error in the spot area. Specifically, first, a regression equation is obtained that shows the change over time between the light amount of the marker spot SP2 and the light amount of the detection probe spot SP1. Then, the light amount of the detection probe spot SP1 is predicted from the light amount of the marker spot SP2 obtained in step S14 according to the regression equation, and the threshold value TH0 is corrected.
[0113] <Diagnosis of abnormalities in nucleic acid sequence measurement devices> A threshold value defining an upper limit and a lower limit of the light amount of the marker spot SP2 may be set based on the light amount of the marker spot SP2 acquired in advance, and the calculation unit 25 may diagnose and notify an abnormality when the light amount of the marker spot SP2 exceeds the threshold value. The upper threshold value may be set, for example, based on an error such as noise in the image acquisition unit 12a or abnormal light emission derived from the sample, and an empirical value of the light amount of the marker spot SP2.
[0114] The lower threshold value is determined by checking the detection limit in advance with respect to the decrease in light intensity due to deterioration of the detection probe spot SP1 over time, using the number of target molecules in the sample as a parameter, and setting a range of light intensity that is not affected by the detection limit in the detection probe spot SP1 with a decreased light intensity. Then, the marker spot light intensity in the range that does not affect the detection limit of the detection probe can be obtained and used as the lower threshold value.
[0115] As a possible range of light intensity correction by the marker spot SP2, a range of the marker spot light intensity that deviates from the linear or nonlinear model of the correlation between the light intensity of the marker spot SP2 and the deterioration over time of the detection probe spot SP1 can be obtained in advance. The threshold value may be set in multiple stages, such as two stages, rather than one stage. When the threshold value is set in two stages, for example, a threshold value that specifies that there is a problem with the measurement value and a threshold value that specifies that the value is clearly abnormal can be set.
[0116] Furthermore, the nucleic acid sequence measuring apparatus, the nucleic acid sequence measuring method, the nucleic acid sequence measuring program, and the nucleic acid sequence measuring device according to the embodiments of the present invention can be used for dry image measurement in measuring the amount of fluorescent molecule light, liquid observation of the amount of fluorescent molecule light in a biochip, real-time observation in continuous reactions, etc. Specifically, they can be used for example for bacterial species discrimination by gene / polymer analysis, cancer genes, animal and plant discrimination, intestinal bacteria testing, etc.
[0117] Furthermore, the nucleic acid sequence measuring device and the nucleic acid sequence measuring method according to the embodiment of the present invention are also applied to the following solid phase methods such as the labeled antibody method used in clinical tests, etc. For example, the FISH method (fluorescent in situ hybridization) is an example of a method for measuring the expression of specific chromosomes or genes in tissues or cells by fluorescence measurement using a fluorescent substance. In addition, the nucleic acid sequence measuring device and the nucleic acid sequence measuring method according to the embodiment of the present invention are applied to various other methods such as the following. That is, the FIA method (fluorescent immunoassay) is an example of a method for measuring antigen-antibody reactions using a fluorescent substance such as europium as a label, and the IFA method (indirect fluorescent antibody method) is an example of a method for measuring serum (antibody) reactions using a fluorescent substance labeled to a pathogen or the like that serves as an antigen. [Explanation of symbols]
[0118] 1. Nucleic acid sequence measurement device 12 Detection section 12a Image acquisition section 25 Arithmetic section BK Block DV Nucleic acid sequence measurement device LN2 Linear SP1 detection probe spot SP2 Marker Spot TG Target TH0 Threshold
Claims
1. A nucleic acid sequence measuring apparatus for measuring a target having a specific nucleic acid sequence contained in a sample, comprising: a detection unit that detects fluorescence emitted from a nucleic acid sequence measurement device having a measurement region that emits a first fluorescence upon reaction with the target and a reference region that emits a second fluorescence regardless of reaction with the target; a calculation unit that measures the target based on a light amount obtained by correcting or normalizing the light amount of the first fluorescence emitted from the measurement region, among the fluorescence detected by the detection unit, using the light amount of the second fluorescence emitted from the reference region; and A nucleic acid sequence measuring device comprising:
2. the nucleic acid sequence measuring device is provided with a plurality of the measurement areas and a plurality of the reference areas, the calculation unit corrects or normalizes a spatial distribution of the light amount of the first fluorescence emitted from the plurality of measurement regions by using the light amount of the second fluorescence emitted from the plurality of reference regions. The nucleic acid sequence measuring device according to claim 1.
3. the calculation unit calculates a coefficient indicating a change in the amount of the second fluorescence along a straight line passing through any two or more of the reference areas, from the amount of the second fluorescence emitted from any two or more of the reference areas; correcting a spatial distribution of the light amount of the first fluorescence emitted from the measurement area located on the straight line by using the coefficient; The nucleic acid sequence measuring device according to claim 2.
4. 4. The nucleic acid sequence measuring apparatus according to claim 3, wherein the coefficient is a coefficient indicating a rate of change in the amount of the second fluorescence along the straight line, or a coefficient based on multiple regression analysis or multivariate analysis of the amount of the second fluorescence along the straight line.
5. 2. The nucleic acid sequence measuring device according to claim 1, wherein the calculation unit uses information indicating positions of the plurality of reference regions, information indicating the amount of the second fluorescence emitted from the plurality of reference regions, and information indicating the position of the measurement region as explanatory variables, and corrects the amount of the first fluorescence emitted from the measurement region using the correction coefficient obtained by substituting the explanatory variables into a learning model trained using a correction coefficient in the measurement region as a response variable.
6. 2. The nucleic acid sequence measuring device according to claim 1, wherein the calculation unit corrects the amount of the first fluorescence emitted from the measurement region based on the amount of the second fluorescence emitted from the reference region using a relational equation showing a relationship between a change over time in the amount of the first fluorescence emitted from the measurement region and a change over time in the amount of the second fluorescence emitted from the reference region.
7. 2. The nucleic acid sequence measuring device according to claim 1, wherein the calculation unit extracts the measurement region using a predetermined light intensity threshold, and corrects the light intensity threshold according to the light intensity of the second fluorescent light emitted from the reference region.
8. 2. The nucleic acid sequence measuring device according to claim 1, wherein the calculation unit notifies the fact that an abnormality exists when the amount of the second fluorescent light emitted from the reference region exceeds a preset upper threshold or a preset lower threshold.
9. In the nucleic acid sequence measuring device, the measurement area and the reference area are divided into partitioned areas each having a predetermined number as a unit, The detection unit includes an image acquisition unit that acquires an image of the divided area. The nucleic acid sequence measuring device according to claim 1.
10. A method for measuring a nucleic acid sequence comprising the steps of: measuring a target having a specific nucleic acid sequence contained in a sample; A nucleic acid sequence measuring method comprising: a nucleic acid sequence measuring device having a measurement region that emits a first fluorescence in response to a reaction with the target, and a reference region that emits a second fluorescence regardless of a reaction with the target, the measurement region having a first fluorescence emitted from the measurement region, the reference region having a second fluorescence emitted from the measurement region, and a calculation step of measuring the target based on an amount of light obtained by correcting or normalizing the amount of light of the first fluorescence emitted from the measurement region using the amount of light of the second fluorescence emitted from the reference region.
11. A nucleic acid sequence measuring program for causing a computer to execute a calculation step of measuring the target based on an amount of fluorescence emitted from a nucleic acid sequence measuring device having a measurement area that emits a first fluorescence in response to a reaction with a target having a specific nucleic acid sequence contained in a sample, and a reference area that emits a second fluorescence regardless of a reaction with the target, the amount of the first fluorescence emitted from the measurement area being corrected or normalized using the amount of the second fluorescence emitted from the reference area.
12. A nucleic acid sequence measuring device used to measure a target having a specific nucleic acid sequence contained in a sample, comprising: a measurement area that emits a first fluorescence upon reaction with the target; a reference region that emits a second fluorescence regardless of a reaction with the target; A nucleic acid sequence measuring device comprising:
13. 13. The nucleic acid sequence measuring device according to claim 12, wherein the measurement region and the reference region are divided into partitioned regions each having a predetermined number as a unit.
Citation Information
Patent Citations
A method for immobilization of hydrogels over unmodified polymer materials,a biochip based on unmodified polymer materials,and a method for manufacuturing the
GB2435473A
Microarray, method of manufacturing it, and method for correcting error in amount of spot between pins of microarray
JP2001249130A
Image reader
JP2001298614A
Method for detecting analytes in fluid samples
JP2013509581A
DNA chip for detecting dental caries
JP2018148855A
